Young Age Onset Multivascular Pathology in a Patient with Severe Dyslipidemia: an Incidental Case or a Particular Type of Familial Hypercholesterolemia?
This work is licensed under the Creative Commons Attribution 4.0 International License.
Varghese MJ. Familial hypercholesterolemia: A review. Ann Pediatr Cardiol 2014; 7(2):107–117.VargheseMJFamilial hypercholesterolemia: A review20147210711710.4103/0974-2069.132478407019924987256Search in Google Scholar
Hao W, Friedman A. The LDL-HDL profile determines the risk of atherosclerosis: A mathematical model. PLoS One 2014; 9(3):e90497.HaoWFriedmanAThe LDL-HDL profile determines the risk of atherosclerosis: A mathematical model201493e9049710.1371/journal.pone.0090497395126424621857Search in Google Scholar
Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 1988; 4(suppl A):5A–10.CastelliWPCholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study19884suppl A5A10Search in Google Scholar
Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003; 23:1881–88.KontushAChantepieSChapmanMJSmall, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress20032318818810.1161/01.ATV.0000091338.93223.E812920049Search in Google Scholar
Rader DJ. High-density lipoproteins and atherosclerosis. Am J Cardiol 2002; 90:62–70.RaderDJHigh-density lipoproteins and atherosclerosis200290627010.1016/S0002-9149(02)02635-8Search in Google Scholar
Francis MC, Frohlich JJ. Coronary artery disease in patients at low risk: Apolipoprotein AI as an independent risk factor. Atherosclerosis 2001; 155:165–70.FrancisMCFrohlichJJCoronary artery disease in patients at low risk: Apolipoprotein AI as an independent risk factor20011551657010.1016/S0021-9150(00)00528-111223438Search in Google Scholar
Leigh SE, Leren TP, Humphries SE. Commentary PCSK9 variants: A new database. Atherosclerosis 2009; 203(1):32–33.LeighSELerenTPHumphriesSECommentary PCSK9 variants: A new database20092031323310.1016/j.atherosclerosis.2009.02.00619249440Search in Google Scholar
Guo Y, Yan B, Gui Y, Tang Z, Tai S, Zhou S et al. Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall. J Cell Physiol 2020; 236(4):2333–51.GuoYYanBGuiYTangZTaiSZhouSPhysiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall2020236423335110.1002/jcp.3002532875580Search in Google Scholar
Pinard A, Jones GT, Milewicz DM. Genetics of thoracic and abdominal aortic diseases. Circ Res 2019; 124(4):588–606.PinardAJonesGTMilewiczDMGenetics of thoracic and abdominal aortic diseases2019124458860610.1161/CIRCRESAHA.118.312436642842230763214Search in Google Scholar
Tanaka H, Inuzuka K, Iida Y, Shimizu H, Unno N, Urano T. Proprotein convertase subtilisin / kexin type 9 is associated with degenerating adipocytes in abdominal aortic aneurysm. J Oleo Sci 2018; 67(10):1355–60.TanakaHInuzukaKIidaYShimizuHUnnoNUranoTProprotein convertase subtilisin / kexin type 9 is associated with degenerating adipocytes in abdominal aortic aneurysm2018671013556010.5650/jos.ess1813130210081Search in Google Scholar
Puntoni M, Sbrana F, Bigazzi F, Sampietro T. Tangier disease: Epidemiology, pathophysiology, and management. Am J Cardiovasc Drugs 2012; 12(5):303–11.PuntoniMSbranaFBigazziFSampietroTTangier disease: Epidemiology, pathophysiology, and management20121253031110.1007/BF03261839Search in Google Scholar
Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370:1829–39.Prospective Studies CollaborationLewingtonSWhitlockGClarkeRSherlikerPEmbersonJBlood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths200737018293910.1016/S0140-6736(07)61778-418061058Search in Google Scholar
Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis. JAMA 2016; 316:1289–97.SilvermanMGFerenceBAImKWiviottSDGiuglianoRPGrundySMAssociation between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis201631612899710.1001/jama.2016.1398527673306Search in Google Scholar